Brian Lee

Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL.

The Commonwealth Government provides legislature, executive and judiciary services. It is located in Canberra, Australia.

The Kavli Foundation engages in the provision of support for the advancement of science, increase of public understanding, and support for scientists. The company was founded by Fred Kavli in December 2000 and is headquartered in Los Angeles, CA.

Outotec Ausmelt Pty Ltd. designs and supplies Top Submerged Lance (TSL) smelting technology. It offers TSL, a bath smelting technique with wide application in the non-ferrous, ferrous, and precious metals industry. The company was founded by Dr. John Floyd in 1981 and is headquartered in Melbourne, Australia.

Allied Corporation are in Textile parts (Spinning) business for more than 8 year, want to import from China. Manufactures rubber aprons cots for textile industries. It also does spinning parts business in Pakistan. Allied Corporation is headquartered at Faisalabad Pakistan

Commonwealth Scientific & Industrial Research Organisation provides scientific and industrial research services. It plays a role in collaboration within the Australian national innovation system and as an advisor to government, industry and the community. The company was founded in 1916 and is headquartered in Canberra, Australia.

Mayo Clinic provides health care services. Its products and services include healthy living program, sports medicine, Mayo clinic health letter, medical products, population health and wellness programs, medical laboratory services and mayo clinic voice apps. The firm offers medical services in the areas of dermatology, allergy, hypertension, neurology, oncology, psychiatry, radiation oncology, and rheumatology. The company was founded by William J. Mayo and Charles H. Mayo in 1986 and is headquartered in Rochester, MN.

Mayo Foundation for Medical Education & Research operates as a medical care research and education organization. Its services include patient care, corporate services, research, and education. The company was founded in 1984 and is headquartered in Rochester, MN.

The National Collegiate Athletic Association administers intercollegiate sports activities. The company was founded in 1905 and is headquartered in Indianapolis, IN.

The Knight Commission on Intercollegiate Athletics is an organization that advocates for reforms to enhance the educational aspect of college sports. The non-profit company is based in Washington. The commission aims to support and strengthen the educational mission of college sports.

BTF Pty Ltd. develops biological products. Its products include microorganism testing products such as BioBall, EasySeed, ColorSeed, EasyStain, and EasyPC. The company was founded Mark Gauci and Graham Vesey in March 1999 and is headquartered in North Ryde, Australia

Kestrel Capital Pty Ltd. is a private equity/venture capital firm founded in 1993 by Niall Charles Edgar Cairns. The firm is headquartered in New South Wales, Australia.

Universal Biosensors Pty Ltd. manufactures diagnostic test systems. Its products include blood glucose monitoring and coagulation testing. The company was founded in 2001 and is headquartered in Rowville, Australia.

Part of Danaher Corp., Pall Asia International Ltd. is a Chinese company that manufactures and distributes fluid testing and medical devices. The company is based in Hong Kong, Hong Kong.

ANU Connect Ventures Pty Ltd (ANU Connect Ventures) is a venture capital subsidiary of Australian National University founded in 2005. The firm is headquartered in Canberra, Australia.

TGR BioSciences Pty Ltd. engages in the development of drug discovery technologies and products. Its products include captsure technology, Elisa one, surefire, alpha surefire and alpha surefire ultra multiplex. The company was founded by Leanna C. Read in 2001 and is headquartered in Thebarton, SA.

Part of RTX Corp., Pratt & Whitney Aircraft Co. is a manufacturer of gas turbine, airframe, and nacelle components.

SpeeDx Pty Ltd. is a medical diagnostic company focused on the research, development and commercialization of molecular diagnostic detection technologies. It offers various technologies, including MNAzymes, which are multi-component nucleic acid enzymes composed of DNA to be adapted for sensitive and specific multiplexed detection of various target analytes, as well as catalytically modify substrates producing signals to indicate the presence of target; DNAzymes, which are deoxyribozymes or DNA enzymes to catalyze a repertoire of chemical reactions and are used in the sensor/nanotechnology arena, as well as used for human and animal health; and EzyAmp, an isothermal signal amplification cascade that utilizes restriction enzymes. The company was founded by Elisa E. Mokany and Alison V. Todd in 2009 and is headquartered in Eveleigh, Australia.

Vaxxas Pty Ltd. develops and commercializes needle-free vaccine delivery system solutions. Its flagship products, Nanopatch, consists of an array of thousands of vaccine coated microprojections that perforate into the outer layers of the skin when applied with an applicator device. The tips of Nanopatch's microprojections are coated with a vaccine material and release this material directly to the large numbers of key immune cells immediately below the skin surface. The company was founded by Mark Kendall in August 2011 and is headquartered in Sydney, Australia.

Part of Immix Biopharma, Inc., Nexcella, Inc. is a clinical-stage biopharmaceutical company based in Los Angeles, CA. The company is engaged in the discovery and development of novel cell therapies for oncology and other indications. Nexcella's lead candidate, next generation bcma-targeted car-t nxc-201, has produced high response rates in relapsed/refractory al amyloidosis and relapsed/refractory multiple myeloma, and has been awarded orphan drug designation by the FDA in both indications. The company's n-genius platform allows for the discovery, development, and manufacture of cutting-edge cell therapies for patients in need. Expansion into autoimmune indications is planned.